Skip to content
Telix Pharmaceuticals
-
Telix inks US$1.67B acquisition deal for Germany’s ITM Isotope Technologies
Following completion of the acquisition, ITM shareholders are expected to hold 23.7% of Telix, while existing Telix shareholders will retain 76.3%.